期刊文献+

胰高血糖素样肽-2/聚乳酸-羟基乙酸微球的制备及其体外释药性质研究 被引量:6

Preparation and in Vitro Release Property of Glucagon-like Peptide-2/PLGA Microspheres
原文传递
导出
摘要 目的:制备胰高血糖素样肽-2(GLP-2)/聚乳酸-羟基乙酸(PLGA)微球,并对其体外释药特性进行研究。方法:通过L(93)4正交试验设计优选微球最佳制备工艺条件,采用复乳-溶剂挥发法制备GLP-2/PLGA微球,并对制备工艺的重现性、所制微球的性质及体外释药性能进行考察。结果:优选的GLP-2/PLGA微球的最佳制备工艺稳定、重现性好;微球形态圆整,粒度分布均匀,平均粒径为14.49μm,载药量为13.48%,包封率为36.97%,微球在6 d内释药缓慢而均匀。结论:建立的制备工艺条件稳定、可行,所制微球初步达到了预期的试验目的。 OBJECTIVE: To prepare Glucagon-like peptide-2(GLP-2)/poly(lactide-co-glycolide acid)(PLGA) microsphere,and to study in vitro drug release property of the microsphere.METHODS: L9(34) orthogonal experiment design was introduced to optimize the preparation process of microsphere.GLP-2/PLGA microsphere was prepared by double emulsion(W/O/W) solvent evaporation method.Reproducibility of preparation process,in vitro release property and physical characteristics of microsphere were investigated.RESULTS: Optimized preparation process of GLP-2/PLGA microsphere was stable and reproducible.Microsphere showed even and regular appearance with mean particle size of 14.49 μm.The drug-loading rate was 13.48% and encapsulation efficiency was 36.97%.The drug release behavior was slow and regular in 6 days.CONCLUSION: The optimized preparation process is stable and practical.Prepared microspheres meet the expected experiment purpose.
出处 《中国药房》 CAS CSCD 北大核心 2010年第29期2755-2757,共3页 China Pharmacy
关键词 胰高血糖素样肽-2 聚乳酸-羟基乙酸 微球 制备 体外释药性 Glucagon-like peptide-2 Poly(lactide-co-glycolide acid) Microsphere Preparation In vitro release property
  • 相关文献

参考文献4

二级参考文献41

  • 1平其能 郑梁元.药用聚合物的理论和实践[M].北京:中国医药科技出版社,1994.410-412.
  • 2[1]Kieffer TJ, Habener JE. The glucagons-like peptides[J]. Endocr Rev, 1999, 20:876-913.
  • 3[2]Drucker DJ. Glucagons-like peptides2 [ J ]. Trends Endocrinol Metab,1999, 10:153 - 156.
  • 4[3]Drucker DJ. The glucagons-like peptides[J]. Diabetes, 1998,47:159 - 169.
  • 5[4]Dhanvantari S, Seidah NG, Brubaker PL. Role of prohormone convertases in the tissue-specific processing of proglucagon [ J].Mol Endocrinol, 1996, 10:342 -355.
  • 6[5]Iniin DM, Wong J. Trout and chicken proglucagon: alternative splicing generates mRNA transcripts encoding glucagons-like peptide 2[J]. Mol Endocrinol, 1995, 9:267 -277.
  • 7[6]Chen YE, Drucker DJ. Tissue-specific expression of unique mRNAs that encode proglucagon derived peptides or exendin 4 in the lizard[J]. J Biol Chem, 1997, 272(7) :4108 -4115.
  • 8[7]Drucker DJ, Ehrlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagons-like peptide 2 [J ]. Proc Natl Acad Sci USA, 1996, 93:7911 -7916.
  • 9[8]Gleeson MH, Bloom SR, Polak JM, et al. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function[J]. Gut, 1971, 12(10) :773 -782.
  • 10[9]Stavens FM, Flanagan RW, O Gorman D, et al. Glucagonoma syndrome demonstrating giant duodenal villi [ J ]. Gut, 1984, 25:784 - 791.

共引文献17

同被引文献81

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部